novartis hit acquisition trail swiss drugmaker novartis announce 565bn euro 74bn 39bn purchase make sandoz unit world big generic drug producer novartis last month forecast record sale 2005 say bought germany hexal also acquire 677 hexals us affiliate eon lab offer buy remain share 31 novartis say able make cost saving 200m year follow acquisition novartis share rise 1 5785 swiss franc early trading deal will see novartis sandoz business overtake israel teva pharmaceutical world big maker generic base 2004 figure newly merge producer sale 5bn company estimate novartis say merge number department add may job cut strong growth outlook sandoz will create job expect partially compensate necessary reduction work force firm say statement generic drug chemically identical expensive brand rival producer sandoz can copy brand product usually patent protection expires can sell cheaply pay research development cost 150 generic drugmakers worldwide analyst predict consolidation market call fragment however analyst initially convince deal expensive acquisition birgit kuhlhoff sal oppenheim investment bank told reuters find strange make acquisition exactly market suffer price pressure 